May 15th 2024
Determining treatment options for patients with locally advanced rectal cancer after the PROSPECT trial data readout adds an important level to the decision-making process.
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®
View More
2024 International Symposium of Gastrointestinal Oncology (ISGIO)
October 11-12, 2024
Register Now!
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape
View More
Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®
View More
Nurse-Led Care Coordination After Colorectal Cancer Surgery Failed to Show Effect
September 18th 2013The use of a centralized nurse-led telephone-based care coordination system failed to improve outcomes including quality of life, unmet supportive needs or visits to the emergency department after surgical resection of colorectal cancer, according to the results of a new study.
Personalized Medicine in the Adjuvant Chemotherapy of Stage II Colon Cancer-Are We There Yet?
August 15th 2013Over the past few years, significant efforts have focused on developing and validating molecular biomarkers to better define the subset of patients with stage II disease who might derive benefit from adjuvant therapy.
Use of Molecular Biomarkers to Inform Adjuvant Therapy for Colon Cancer
August 15th 2013In this review, we will discuss adjuvant chemotherapy in non-metastatic colon cancer, the existing prognostic and predictive molecular biomarkers in the field, and how to integrate these molecular biomarkers into the decision about whether to administer adjuvant therapy.
Role of Aspirin in Colorectal Cancer Prevention and Treatment
July 9th 2013In this interview we discuss the role of aspirin in colorectal cancer prevention and treatment. Various studies have suggested that a daily aspirin pill can help prevent certain types of cancers. Other studies suggest that there may even be a role for aspirin in treating cancer.
Study: Red Meat Tied to Poor Colorectal Cancer Outcomes
July 4th 2013A study of colorectal cancer survivors shows those who consume higher amounts of red and processed meats before a colorectal cancer diagnosis are at higher risk of death from any cause compared to those who eat less of both types of meat.
ASCO: Cetuximab Ups Survival Over Bevacizumab in Colorectal Cancer
June 14th 2013Results from the German AIO KRK-0306 study, FIRE-3, show that the addition of cetuximab (Erbitux) to chemotherapy rather than bevacizumab (Avastin) increased overall survival by nearly 4 months in patients with KRAS wild-type metastatic colorectal cancer.
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
April 22nd 2013Women diagnosed with endometrial cancer at age 50 or younger had a fourfold increased risk for a subsequent colorectal cancer diagnosis, according to a historical cohort study published recently in the Journal of Clinical Oncology.
ASCO GI: Three Molecular Colorectal Cancer Subtypes in New Diagnostic Classification System
January 30th 2013An international group of researchers have collaborated on an unbiased genome-wide analysis of colorectal cancer, coming up with three distinct molecular subtypes that are potentially clinically relevant and are varying in their biology and clinical outcomes.
ASCO GI: Phase III Bevacizumab Results of the AVEX and TRIBE Trials
January 28th 2013The same week that bevacizumab (Avastin) received a new indication for the treatment of metastatic colorectal cancer, results from two phase III trials involving the drug were presented at the American Society of Clinical Oncology 2013 Gastrointestinal Cancers Symposium (ASCO GI) held January 24–26 in San Francisco.
ASCO GI: Latest Treatments and Research in Gastrointestinal Cancers
January 25th 2013In this interview we discuss the latest treatments and research for gastrointestinal cancers with Dr. Cathy Eng, associate professor, department of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center.
Study: US Cancer Screening Rates Declined Over Last Decade
January 4th 2013There has been a decline in overall cancer screening among the US population. Only colorectal cancer screening rates met current screening goals. Cancer survivors specifically met current national screening goals with the exception of cervical cancer screening.
Early End-of-Life Discussions Affect Aggressiveness in Treating Incurable Cancers
December 12th 2012Initiating discussions about end-of-life care with patients with incurable cancers early in their disease was associated with a decrease in late-stage aggressive cancer treatments such as chemotherapy or acute care, and with an increase in the use of hospice care at the end of life.
Researchers Identify Biomarker for Cancer Resistance
November 28th 2012Researchers have found a novel cellular mechanism that determines resistance to various targeted cancer therapies and several different cancers. The gene may be a key biomarker that could predict responses and provide better strategies to treat drug-resistant cancers.
ESMO: New Agent, MGN1703, for Metastatic Colorectal Cancer Effective as Maintenance Therapy
October 10th 2012Maintenance therapy with a new immunomodulator agent called MGN1703 improves progression-free survival over placebo in patients with metastatic colorectal cancer, according to a new study presented at the ESMO 2012 Congress.